Catalyst Wire Dossier Catalyst Wire Dossier

Pulmozyme

dornase alfa · Genentech (Roche)
Drug timelines are a Plus or Pro feature.

28 regulatory and trial events tracked for Pulmozyme, covering 2006-09-14 to 2026-01-22. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy of Pulmozyme® on Arterial Recanalization in Post-thrombectomy Patients Managed for Ischemic Stroke (NETs-target) [Phase 2]

See pricing